As the biopharmaceutical industry prepares to convene for Cambridge Healthtech Institute's 18th Annual Bioprocessing Summit, taking place August 10-13, 2026, in Boston, this year's program will focus
DENVER, July 28, 2026--As artificial intelligence reshapes cybersecurity, risk management, and enterprise leadership, organizations are looking for practical strategies—not just predictions—to navigat
OPKO Health Inc (OPK) reports significant revenue growth in pharmaceuticals and a notable reduction in net loss, despite challenges in diagnostics.
The drugmaker's rapid stock gains have led to a premium valuation, forcing investors to question its capacity for future growth.
BMY heads into Q2 earnings with growth drugs driving momentum as legacy products decline, setting the stage for a closely watched earnings report.
Here is a way to get paid a significant income stream today from Eli Lilly stock, which you keep no matter what, while setting a price far below current levels where you would be willing to buy.
VRTX heads into its Q2 earnings release with Trikafta, Alyftrek, Casgevy and Journavx in focus as investors watch product sales and updates on ongoing pipeline studies.
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity sca
View interactive chart, options flow, and AI analysis for PFE on Zorveq Finance.
Open PFE Chart & Analysis →